Miaoshou Doctor, a Chinese online healthcare services platform that has expanded into the offline pharmacy space, has completed its extended Series C funding round, having achieved a post-deal valuation of more than RMB7 billion ($1 billion).
Miaoshou Doctor is a China-based health care platform that enables patients to consult with doctors remotely and get prescription drugs from pharmacies.